A drug administered to a patient for treatment, listed in
SEER*Rx as a chemotherapeutic,
hormonal or immunotherapy agent should be coded under chemotherapy [#1390],
hormone therapy [#1400] or immunotherapy [#1410] regardless of the primary site(s)
listed in SEER*Rx for that agent. Do not code under the data item,
Other Therapy [NAACCR #1420]. Refer to the
2026 SEER manual
for more information.
|
Dexrazoxane
|
Ancillary Agent
|
|
No
|
|
Mannitol
|
Ancillary Agent
|
|
No
|
|
Lonidamine
|
Ancillary Agent
|
|
No
|
|
Dianoxide Furoate
|
AIDS drug
|
|
No
|
|
Loviride
|
AIDS drug
|
|
No
|
|
Dextran Sulfate
|
AIDS drug
|
|
No
|
|
Tioconazole
|
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
|
Desmethyl-misonidazole
|
Ancillary Agent
|
|
No
|
|
Filmix
|
Ancillary Agent
|
Liver cancer,
Prostate
|
No
|
|
Testosterone Phenylacetate
|
Hormones and hormonal mechanisms
|
|
No
|
|
Gossypol acetic acid
|
Differentiation inducing agent
|
Prostate cancer
|
No
|
|
Defosfamide
|
Ancillary Agent
|
|
No
|
|
Loxoribine
|
Ancillary Agent
|
|
No
|
|
Delavirdine Mesylate
|
AIDS drug
|
|
No
|
|
N-acetylcysteine
|
AIDS drug
|
|
No
|
|
Mycophenolic acid
|
Ancillary Agent
|
|
No
|
|
Mucopirocin
|
AIDS drug
|
|
No
|
|
Ryoncil
|
Other therapy
|
|
No
|
|
MN rgp120/HIV-1
|
AIDS drug
|
|
No
|
|
Fialuridine
|
AIDS drug
|
|
No
|
|
Testosterone Ketolaurate
|
Hormones and hormonal mechanisms
|
|
No
|
|
Testosterone Enanthate
|
Hormones and hormonal mechanisms
|
|
No
|
|
Tariquidar
|
Ancillary Agent
|
Breast,
Cervix,
Lung,
Ovarian cancer
|
No
|
|
Terconazole
|
AIDS drug
|
|
No
|
|
Dapsone
|
AIDS drug
|
|
No
|
|
Azathioprine
|
Ancillary Agent
|
|
No
|
|
Deferoxamine
|
Ancillary Agent
|
|
No
|
|
Sucralfate
|
Ancillary Agent
|
|
No
|
|
Sulfadiazine
|
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
|
Deoxynojirimycin
|
AIDS drug
|
|
No
|
|
Urokinase
|
Ancillary Agent
|
|
No
|
|
Naproxen Sodium
|
Ancillary Agent
|
|
No
|
|
Fluorothymidine
|
AIDS drug
|
|
No
|
|
Mycophenolate Mofetil
|
Ancillary Agent
|
|
No
|
|
Myristic acid analogs
|
AIDS drug
|
|
No
|
|
Mupirocin
|
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
|
MPI5020
|
Ancillary Agent
|
Breast cancer
|
No
|
|
Midazolam Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Fansidar
|
Ancillary Agent,
AIDS drug
|
|
No
|
|
Trestolone Acetate
|
Hormones and hormonal mechanisms
|
|
No
|
|
NeoTide
|
Ancillary Agent
|
Lung cancer
|
No
|
|
Flucytosine
|
AIDS drug
|
|
No
|
|
Netivudine
|
AIDS drug
|
|
No
|
|
EF-5
|
Ancillary Agent
|
Breast,
Cervical,
Lung,
Prostate cancer
|
No
|
|
Foscarnet Sodium
|
AIDS drug
|
|
No
|
|
Testosterone Undecanoate
|
Hormones and hormonal mechanisms
|
|
No
|
|
Thymopentin
|
AIDS drug
|
|
No
|
|
L-BSO
|
Ancillary Agent
|
|
No
|
|
Atovaquone
|
AIDS drug
|
|
No
|
|
Etidronate Disodium
|
Ancillary Agent
|
|
No
|
|
D4T
|
AIDS drug
|
|
No
|
|
Danazol
|
Ancillary Agent,
Hormones and hormonal mechanisms
|
|
No
|
|
Ethambutol Hydrochloride
|
AIDS drug
|
|
No
|
|
Lithium Carbonate
|
Ancillary Agent
|
|
No
|
|
Etoprine
|
Ancillary Agent
|
|
No
|
|
Ethacrynic Acid
|
Ancillary Agent
|
|
No
|
|
Levulan
|
Ancillary Agent
|
Bladder cancer
|
No
|
|
Levonantradol
|
Ancillary Agent
|
|
No
|
|
Etretinate
|
Differentiation inducing agent
|
|
No
|
|
Triflupromazine Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Letrazuril
|
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
|
Sulindac
|
Ancillary Agent
|
|
No
|
|
Trimethoprim
|
Ancillary Agent,
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|
|
U-87201E
|
AIDS drug
|
|
No
|
|
Trimethobenzamide Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Trospectomycin Sulfate
|
AIDS drug
|
|
No
|
|
Naltrexone Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Nalaxone Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Nabilone
|
Ancillary Agent
|
|
No
|
|
N1177
|
Ancillary Agent
|
Other cancer
|
No
|
|
Metoclopramide
|
Ancillary Agent
|
|
No
|
|
Trichosanthin
|
AIDS drug
|
|
No
|
|
Flurbiprofen
|
Ancillary Agent
|
|
No
|
|
Endorphin
|
Ancillary Agent
|
|
No
|
|
EMLA Cream (lidocaine 2.5% and prilocaine 2.5%)
|
Ancillary Agent
|
|
No
|
|
MSL-109
|
AIDS drug
|
|
No
|
|
U-85961
|
AIDS drug
|
|
No
|
|
Epoetin Alfa
|
AIDS drug,
Ancillary Agent
|
|
No
|
|
Proscar
|
Hormones and hormonal mechanisms
|
Prostate
|
No
|
|
Morphine Sulfate
|
Ancillary Agent
|
|
No
|
|
Famciclovir
|
AIDS drug
|
|
No
|
|
Molybdenum
|
Ancillary Agent
|
|
No
|
|
Tropisetron
|
Ancillary Agent
|
|
No
|
|
Plerixafor
|
Ancillary Agent
|
MM,
Multiple myeloma,
NHL,
Non-hodgkins Lymphoma
|
No
|
|
Mirostepin
|
Ancillary Agent
|
Breast cancer
|
No
|
|
Fluconazole
|
Ancillary Agent,
AIDS drug
|
|
No
|
|
Methylphenidate Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Misonidazole
|
Ancillary Agent
|
|
No
|
|
Ethionamide
|
AIDS drug
|
|
No
|
|
Nevirapine
|
AIDS drug
|
|
No
|
|
TLC G-65
|
AIDS drug
|
|
No
|
|
Trans-Retinoic Acid
|
Differentiation inducing agent
|
Leukemia,
skin cancer
|
No
|
|
Theophylline
|
Ancillary Agent
|
|
No
|
|
Erythropoietin
|
Ancillary Agent
|
AIDS,
Opportunistic infection
|
No
|
|
U-90152
|
AIDS drug
|
|
No
|
|
TIBO derivatives
|
AIDS drug
|
|
No
|
|
Thiabendazole
|
AIDS drug
|
|
No
|
|
Thymic Humoral Factor
|
AIDS drug
|
|
No
|
|
Methadone Hydrochloride
|
Ancillary Agent
|
|
No
|
|
Malathion
|
AIDS drug
|
AIDS,
Opportunistic infection
|
No
|